Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | AMGN | REGN | VRTX | BMY |
| Company | Gracell Biotechnologies Inc ADR | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 10.26 | 324.70 | 1,150.00 | 467.92 | 49.79 |
| High | 10.28 | 326.97 | 1,152.87 | 471.89 | 50.03 |
| Low | 10.17 | 319.00 | 1,128.97 | 463.04 | 48.53 |
| Last | 10.25 | 320.56 | 1,131.50 | 468.00 | 48.70 |
| Change | +0.01 | -3.80 | -19.06 | -0.57 | -1.10 |
| % Change | +0.05% | -1.17% | -1.66% | -0.12% | -2.21% |
| Volume | 6,417,100 | 2,242,400 | 616,600 | 1,090,300 | 11,146,300 |
| 20-Day Average Volume | 1,332,340 | 1,698,475 | 437,070 | 1,051,725 | 10,211,365 |
| Previous Close | 10.25 | 324.36 | 1,150.56 | 468.57 | 49.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 326.43 | 1,173.88 | 478.84 | 48.81 |
| 20-Day Raw Stochastic | 53.16% | 14.83% | 21.25% | 23.60% | 51.99% |
| 20-Day Relative Strength | 72.75% | 46.19% | 49.70% | 43.84% | 55.44% |
| Weighted Alpha | +228.20 | +22.37 | +38.50 | +32.41 | -14.34 |
| Today's Opinion | 100% Buy | 56% Buy | 80% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 80% Buy | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Buy | 56% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | -3.16% since 08/29/24 | -4.02% since 08/29/24 | -5.14% since 08/29/24 | -2.05% since 08/29/24 |
| Low | 10.09 on 02/16/24 | 319.00 on 09/06/24 | 1,128.97 on 09/06/24 | 463.04 on 09/06/24 | 48.53 on 09/06/24 |
| High | 10.35 on 02/14/24 | 335.66 on 08/30/24 | 1,192.54 on 09/03/24 | 500.25 on 08/30/24 | 50.75 on 09/04/24 |
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | -2.55% since 08/06/24 | +6.13% since 08/06/24 | -1.33% since 08/06/24 | +2.94% since 08/06/24 |
| Low | 9.97 on 01/22/24 | 306.59 on 08/07/24 | 1,061.46 on 08/07/24 | 458.04 on 08/13/24 | 46.22 on 08/08/24 |
| High | 10.44 on 02/09/24 | 335.66 on 08/30/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | +4.86% since 06/06/24 | +13.06% since 06/06/24 | -3.61% since 06/06/24 | +19.13% since 06/06/24 |
| Low | 3.80 on 11/28/23 | 295.30 on 06/13/24 | 992.22 on 06/10/24 | 458.04 on 08/13/24 | 39.35 on 07/05/24 |
| High | 10.44 on 02/09/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | +15.90% since 03/06/24 | +16.40% since 03/06/24 | +13.63% since 03/06/24 | -8.77% since 03/06/24 |
| Low | 2.10 on 10/04/23 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 10.44 on 02/09/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 171,959,600 | 124,675,448 | 120,768,808 | 98,719,768 |
| Shares Outstanding, K | 72,678 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -88,080,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -9,270,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | -0.33 | 0.61 | 0.12 | 0.40 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 03/11/24 | 10/29/24 | 08/01/24 | 08/01/24 | 10/24/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.23 | 29.45 | 0.00 | 35.55 |